EP3909966
19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROID FOR USE IN THERAPY
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
17.4.2014EP published:
9.7.2025EP application number:
21178047.3
EPO information:
European Patent Register
Max expiry date:
16.4.2034
Title in English:
19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROID FOR USE IN THERAPYLanguage of the patent:
English
Timeline
Today
17.4.2014EP application
9.7.2025EP Publication
Owner
Name:
Sage Therapeutics, Inc.Address:
55 Cambridge Parkway, Cambridge, MA 02142, US
Inventor
Name:
BOTELLA, Gabriel MartinezAddress:
Wayland, 01778, US
Name:
HARRISON, Boyd L.Address:
Princeton Junction, 08550, US
Name:
ROBICHAUD, Albert JeanAddress:
New Jersey, 08551, US
Name:
SALITURO, Francesco G.Address:
Marlborough, 01752, US
Name:
BERESIS, Richard ThomasAddress:
Shanghai, 200040, CN
Priority
Number:
PCT/CN2013/074323Date:
17.4.2013Country:
WO
Classification
Categories:
C07J 43/00, A61K 31/57, A61K 31/573, A61K 31/58, A61P 25/00, A61P 9/00, A61P 25/04, A61P 25/08, A61P 25/18, A61P 25/20, A61P 25/22, A61P 25/28, A61P 25/30, A61P 27/16, A61P 25/14, C07J 3/00, C07J 7/00, C07J 15/00, C07J 1/00, C07J 5/00, C07J 13/00, C07J 21/00, C07J 31/00